Aclaris Therapeutics, Inc.
ACRS
$1.57
$0.063.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.83% | -4.63% | 23.94% | -7.25% | -24.96% |
| Total Receivables | -32.98% | 2,892.62% | -0.87% | -24.59% | -45.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.55% | -63.62% | -78.32% | -51.16% | -47.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -19.62% | -2.25% | 7.53% | -11.51% | -26.59% |
|
|
|||||
| Total Current Assets | -19.62% | -2.25% | 7.53% | -11.51% | -26.59% |
| Net Property, Plant & Equipment | -30.46% | -29.73% | -5.54% | -6.67% | 15.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 58.01% | -25.08% | 215.58% | 240.26% | 16.12% |
| Total Assets | 13.80% | 11.61% | -16.47% | -31.65% | -24.22% |
|
|
|||||
| Total Accounts Payable | -41.22% | -47.17% | -20.58% | -36.38% | 31.99% |
| Total Accrued Expenses | 43.83% | -30.01% | -63.16% | -61.08% | -56.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -0.99% | 12.91% | 50.00% | -1.97% | -16.58% |
| Total Finance Division Other Current Liabilities | 80.59% | 74.45% | -14.65% | 107.13% | 153.59% |
| Total Other Current Liabilities | 80.59% | 74.45% | -14.65% | 107.13% | 153.59% |
| Total Current Liabilities | 7.14% | 2.08% | -31.13% | -31.31% | 9.98% |
|
|
|||||
| Total Current Liabilities | 7.14% | 2.08% | -31.13% | -31.31% | 9.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -33.15% | -31.13% | 22.41% | 24.38% | 50.81% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 239.20% | 400.97% | -5.13% | -70.48% | -72.45% |
| Total Liabilities | 68.57% | 61.02% | -15.77% | -51.25% | -39.41% |
|
|
|||||
| Common Stock & APIC | 14.13% | 14.03% | 1.00% | 1.31% | 4.79% |
| Retained Earnings | -16.53% | -17.13% | -4.81% | -7.93% | -10.87% |
| Treasury Stock & Other | 219.23% | 191.51% | 137.82% | 58.33% | -2.82% |
| Total Common Equity | 1.44% | -1.03% | -16.75% | -25.55% | -19.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.44% | -1.03% | -16.75% | -25.55% | -19.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.44% | -1.03% | -16.75% | -25.55% | -19.68% |
|
|
|||||